瑞鑫國際集團(00724.HK)接獲聯交所復牌指引 繼續停牌
格隆匯11月24日丨瑞鑫國際集團(00724.HK)發佈公吿,2024年11月20日,公司接獲聯交所發出的函件,當中載有有關公司股份在聯交所恢復買賣的指引(“復牌指引”)。根據復牌指引,公司須:(a)刊發上市規則項下規定的所有未發佈財務業績,並解決任何審核修訂;(b)證明公司已遵守上市規則第13.24條;(c)重新遵守第3.10(1)、3.21、3.27A及3.28條;及(d)知會市場所有重大資料,以供公司股東及投資者評估其狀況。
公司股份已自2024年9月2日上午九時正起暫停在聯交所買賣,並將繼續暫停買賣,直至公司履行復牌指引為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.